Key Financials
 
Key financials

Selected Key Figures*

The fiscal year of HELLA ends on May 31.

* Please observe the remarks on the Yearly Figures.

02/05/2016
Sales
EBITDA
EBIT
Consolidated profit
Net financial dept
Equity

Yearly figures

in € million 2015/2016 2014/2015 2013/2014
Sales 6,352 5,835 5,343
Change compared to last year  9% 9% 11%
Adjusted EBITDA* 858
781 708
Change compared to last year  10% 10% 25%
Adjusted EBIT* 476 445
399
Change compared to last year  7% 12% 30%
Consolidated profit 272 295
230
Change compared to last year  -8% 29% 12%
R&D expenses 623
544 514
Change compared to last year  15% 6% 16%
Cash flow from operating activities 602
560 535
Change compared to last year  8% 5% 21%
Net capital expenditures** 463
347 368
Change compared to last year  33% -6% -14%
Net debt 238
131
425
Change compared to last year  82% -69% 3%
Permanent Employees (headcount, on average; not in € million) 32,708 31,484 29,560
Change compared to last year  4% 7% 7%
 


Adjusted EBITDA margin* 13.5% 
13.4%
12.3%
Adjusted EBIT margin* 7.5%
7.6% 7.5%
R&D expenses in relation to sales 9.8% 9.3% 9.6%
Net debt/EBITDA (share) 0.3x 0.2x 0.6x
Equity ratio 39.6% 38.8% 30.1%
Return on equity 14.2% 22.0% 19.0%

* Adjusted for special items from the loss of a supplier in China (€ 47 million) as well as for costs incurred in conjunction with the voluntary partial and severance payment programme (€ 9 million). For further information on the adjusted non-recurring charges, please refer to the current and prior financial statements.
** Settlements for capital expenditures balanced with cash inflows from customer refunds

08/11/2016
 
 

Nine Month Figures

in € million Nine Months
FY 2016/2017
Nine Months
FY 2015/2016
Sales 4,776 4,654
Change compared to previous period
[curency- and portfolio adjusted]
3% [4%] 10% [8%]
EBIT [adjusted] 348 [373] 290 [345]
Change compared to previous period 20% [8%] -6% [9%]
EBITDA 641 582
Change compared to previous period 10% 6%
Earnings for the period 248 184
Change compared to previous period 35% -15%
Earnings per share (in €) 2.21 1.63
Change compared to previous period 35% -19%
R&D expenses 468 449
Change compared to previous period 4% 11%
Free cashflow [adjusted] 9 [86]
-10 [56]
Net capital expenditure 328 297
Change compared to previous period 10% 16%



EBIT margin [adjusted] 7.3% [7.8%] 6.2% [7.4%]
EBITDA margin
13.4% 12.5%
R&D expenses in relation to sales 9.8% 9.6%
Net financial debt 317 300
Net financial debt/EBITDA (last 12 months) 0.4x 0.4x
Equity ratio 42.3% 39.1%
Return on equity (last 12 months) 17.7% 14.7%
Number of employees (headcount; not in € million) 36,068 33,023

 

Further information can be found in the financial information for the quarter and in the further notes.

 

04/05/2017
 
 

Quarterly figures

in € million 3rd quarter 
FY 2016/2017
3rd quarter
FY 2015/2016
Sales 1,578 1,495
Change compared to previous period
[curency- and portfolio adjusted]
6% [6%] 7% [7%]
EBIT [adjusted] 103 [105] 87 [89]
Change compared to previous period 18% [17%] -1% [-2%]
EBITDA 203 182
Change compared to previous period 11% 8%
Earnings for the period 74 53
Change compared to previous period 41% -19%
Earnings per share (in €) 0.65 0.47
Change compared to previous period 38% -16%
R&D expenses 157 157
Change compared to previous period 0% 15%
Free cashflow [adjusted] 16 [19]
-63 [-39]
Net capital expenditure 120 108
Change compared to previous period 11% 73%



EBIT margin [adjusted] 6.5% [6.6%] 5.8% [6.0%]
EBITDA margin
12.9% 12.2%
R&D expenses in relation to sales 9.9% 10.5%

 

Further information can be found in the financial information for the quarter and in the further notes.

04/05/2017
 
 

Sales by business segments

Sales by business segments
As of May 31, 2016
 
 

Regional market coverage

Regional market coverage
As of May 31, 2016
 
 

Employees by regions

Employees by regions

As of May 31, 2016

 
 
 
 
  • icon_druck
  • Youtube
  • linkedin-logo
 
 
 
Financial calendar
2017-08-10Annual Results 2016/17
05/30/2017
2017-09-27Results First Quarter 2017/18
05/30/2017
2017-09-28Annual General Meeting 2017
07/20/2017
 
07/28/2016
Contact

Dr. Kerstin Dodel
Investor Relations
Phone: +49 2941 38 1349
Fax: +49 2941 38 477099
Email: investor.relations@hella.com

 
07/20/2017
Email Service

Register for our Email Service providing access to different HELLA publications.

 
12/04/2014
Stock Chart
 
05/30/2017